You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry

Article metrics

Article menu

Download PDFPDF

XML
Neurology
Original research
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry

 

Online download statistics by month:

Online download statistics by month: August 2021 to June 2025

AbstractFullPdf
Aug 2021444440131
Sep 2021666221
Oct 2021938627
Nov 20211009826
Dec 2021879320
Jan 2022888512
Feb 2022343317
Mar 2022616730
Apr 2022525221
May 2022212124
Jun 2022181623
Jul 2022131011
Aug 2022332913
Sep 2022222232
Oct 2022181716
Nov 2022212025
Dec 2022222015
Jan 2023343018
Feb 2023232321
Mar 2023201919
Apr 2023888
May 2023121010
Jun 2023272217
Jul 2023211911
Aug 2023231622
Sep 202318156
Oct 2023222112
Nov 20231199
Dec 2023252114
Jan 202419194
Feb 2024282819
Mar 2024353649
Apr 2024383519
May 2024182312
Jun 2024353521
Jul 2024201917
Aug 2024292219
Sep 202416169
Oct 202412107
Nov 2024151510
Dec 20242096
Jan 2025302911
Feb 202562616
Mar 2025262519
Apr 2025191617
May 2025292315
Jun 2025220
Total18901807891